Excellent resource!
This app is great. I use it often in teaching sexual health issues. I always recommend others to DL for quick, accurate info.
CDN STBBI Guidelines
Published by:
Health Canada
Description
Note: This application is intended for use by HEALTH PROFESSIONALS, and not the general public. For general information on sexually transmitted infections (STIs), refer to https://www.canada.ca/en/public-health/services/diseases.html
This application provides Canadian health professionals with up-to-date recommendations for the screening, diagnosis, management, and treatment of STIs, including recommendations for antibiotic-resistant gonorrhea, in a convenient, concise, and easy to use format.
It has been developed from the 2010 version of the Canadian Guidelines on Sexually Transmitted Infections (Guidelines) (http://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php) and revised content from 2013 to 2016. These updates reflect emerging issues/trends affecting the management of STIs in Canada. Up-to-date information from other complementary resources has also been incorporated, including key recommendations from the HIV Screening and Testing Guide (2012) and the Management of Hepatitis B - Quick Reference (2013).
The content is reflective of the most current evidence for the management of uncomplicated STIs in adults and youth only. It does not contain information for the management of STIs in pregnant women, children, neonates or complicated infections.
This application is intended to provide information to public health and clinical professionals and does not supersede any provincial/territorial legislative, regulatory, policy and practice requirements or professional guidelines that govern the practice of health professionals in their respective jurisdictions, whose recommendations may differ due to local epidemiology or context.
Hide
Show More...
This application provides Canadian health professionals with up-to-date recommendations for the screening, diagnosis, management, and treatment of STIs, including recommendations for antibiotic-resistant gonorrhea, in a convenient, concise, and easy to use format.
It has been developed from the 2010 version of the Canadian Guidelines on Sexually Transmitted Infections (Guidelines) (http://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php) and revised content from 2013 to 2016. These updates reflect emerging issues/trends affecting the management of STIs in Canada. Up-to-date information from other complementary resources has also been incorporated, including key recommendations from the HIV Screening and Testing Guide (2012) and the Management of Hepatitis B - Quick Reference (2013).
The content is reflective of the most current evidence for the management of uncomplicated STIs in adults and youth only. It does not contain information for the management of STIs in pregnant women, children, neonates or complicated infections.
This application is intended to provide information to public health and clinical professionals and does not supersede any provincial/territorial legislative, regulatory, policy and practice requirements or professional guidelines that govern the practice of health professionals in their respective jurisdictions, whose recommendations may differ due to local epidemiology or context.
Screenshots
CDN STBBI Guidelines FAQ
-
Is CDN STBBI Guidelines free?
Yes, CDN STBBI Guidelines is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is CDN STBBI Guidelines legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does CDN STBBI Guidelines cost?
CDN STBBI Guidelines is free.
-
What is CDN STBBI Guidelines revenue?
To get estimated revenue of CDN STBBI Guidelines app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Netherlands yet.
Ratings History
CDN STBBI Guidelines Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
456
|
CDN STBBI Guidelines Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
Petal for Physicians
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
Lanthier
Internal Medicine
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
Drugs & Drugs
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Bugs & Drugs 2.0
Antimicrobial Reference
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
Thrombosis
|
Unlock
|
Unlock
|
0
|
|
3 months ago | |
RxVigilance Mobile
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
INESSS
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
Mémo Périnatalité
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Firstline - Clinical Decisions
|
Unlock
|
Unlock
|
0
|
1
|
6 days ago | |
IAM Medical Guidelines
|
Unlock
|
Unlock
|
0
|
|
6 months ago |
CDN STBBI Guidelines Installs
Last 30 days
CDN STBBI Guidelines Revenue
Last 30 daysCDN STBBI Guidelines Revenue and Downloads
Gain valuable insights into CDN STBBI Guidelines performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Health Canada
- Languages
- English
- Recent release
- 3.4.1 (7 months ago )
- Released on
- Jan 28, 2015 (9 years ago )
- Also available in
- Canada , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Switzerland , Chile , China , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.